Bhattacharya NR | Author | SciTechnol | Endocrinology & Diabetes

Bhattacharya NR Author

nihardhlt@rediffmail.com +91 9830321927 | +91 98303219

Subjects of specialization
Hydroxychloroquine, Oral hypoglycemic agents, Insulin, HbA1c, Diabetes Mellitus

Affiliation
Consultant Diabetologist, D.H.L.T. Clinic, 2A Banerjee Para Road, Kolkata, India

Biography

Bhattacharya NR Consultant Diabetologist, D.H.L.T. Clinic, 2A Banerjee Para Road, Kolkata, India. His publication include: 1.Jagnani VK, Bhattacharya NR, Satpathy SC, Hasda GC, Chakraborty S (2017) Effect of hydroxychloroquine on type 2 diabetes mellitus unresponsive to more than two oral antidiabetic agents. J Diabetes Metab 8: 771. 2.Pareek A, Chandurkar N, Thomas N (2014) Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 30: 1257-1266.

Publications

Case Report Open Access

A Patient with Uncontrolled Type 2 Diabetes and Dyslipidemia whose Blood Glucose Level is managed by Hydroxychloroquine 400 mg: A Case Report

Author(s):

Bhattacharya NR

Inflammation is considered to play a crucial intermediary role in pathogenesis of diabetes and number of co-existing disease. Hydroxychloroquine (HCQ) works through a novel mechanism and may therefore be a useful adjunctive therapy for patients with T2DM. Here I report a case of a female patient with uncontrolled type 2 diabetes with dyslipidemia who achieve an optimal glycemic control when Hydroxychloroquine was added to the existing pharmacotherapy. The subject has been taking Metformin (500 mg), Glimepiride (2 mg), Voglibose (0.2 mg) and Vildagliptin (500 mg) and a strict exercise regimen for last 2 year but his diabetes was poorly controlled with glycated haemoglobin (HbA1c) of 8.3%. Patient expresses anxiety about using injectable therapy and refused in... view more»

DOI: 10.4172/2470-7570.1000132

Abstract HTML PDF